Stock MDMA PHARMALA BIOTECH HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Pharmala Biotech Holdings Inc.

Equities

MDMA

CA71719L1067

Market Closed - Canadian Securities Exchange
Other stock markets
 03:59:59 2024-06-26 pm EDT 		5-day change 1st Jan Change
0.125 CAD 0.00% Intraday chart for Pharmala Biotech Holdings Inc. 0.00% -10.71%
May. 03 PharmAla Up Near 8% As Launches Prescriber's Portal for Medical Professionals Focused on MDMA Therapy MT
Apr. 23 Red Light Holland Corp. Initiates Psilocybin Extraction Phase with PharmAla CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
PharmAla Up Near 8% As Launches Prescriber's Portal for Medical Professionals Focused on MDMA Therapy
MT
Red Light Holland Corp. Initiates Psilocybin Extraction Phase with PharmAla
CI
Pharmala Biotech Completes $750,000 Private Placement, Debt Settlement
MT
PharmAla Biotech Provides Australian Update
MT
Pharmala Biotech Holdings Inc. Allowance Granted for Ala-002 Composition by US Patent and Trademark Office
CI
Pharmala Biotech Holdings Inc. Signs Sale Agreement with Numinus
CI
PharmAla Says Patent Allowance Granted for P-1 Molecule by USPTO
MT
Pharmala Biotech Holdings Inc. Announces Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office
CI
PharmAla Biotech Holdings Inc. Announces Joint Venture with Cortexa Pty. Ltd
CI
PharmAla Biotech Holdings Inc. Announces Data from its Computational Drug Discovery Program in the Scientific Journal ACS Chemical Neuroscience
CI
Listed Duo PharmAla and Red Light Holland to Collaborate on Medical Psilocybin Development
MT
PharmAla Biotech Holdings Inc. Enters into Consulting Relationship with Red Light Holland Corp
CI
PharmAla Reports Q1 Profit, Provides Business Update
MT
PharmAla up 41%, Granted Controlled Drugs & Substances Dealer's License by Health Canada
MT
Pharmala Biotech Holdings Inc.'s PharmAla-1 Molecule Receives US Patent Prosecution Highway Acceptance
CI
PharmAla Biotech Holdings Inc. Announces World's First Observational Trial to Assess Real-World Efficacy of MDMA Treatment
CI
PharmAla Biotech Received First Office Action for PharmAla-1 PCT Filing
MT
Pharmala Biotech Holdings Inc. Receives First Office Action for PharmAla-1 Pct Filing
CI
PharmAla Biotech Holdings Inc. Ships GMP LaNeo Efficacy to Mind Medicine Australia
CI
PharmAla Biotech Filed Patent for Novel MDXX Molecule PharmAla-1
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MDMA Stock
  4. News Pharmala Biotech Holdings Inc.
  5. Highlights